• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于直方图分析的进展性肺纤维化:肺功能测试与 HRCT 指标之间的关系。

Histogram-based analysis in progressive pulmonary fibrosis: relationships between pulmonary functional tests and HRCT indexes.

机构信息

Department of Medical Surgical Sciences and Advanced Technologies "GF Ingrassia", University Hospital Policlinico "G. Rodolico-San Marco", Catania, Italy.

Radiology Unit 1, University Hospital Policlinico "G. Rodolico-San Marco", Catania, Italy.

出版信息

Br J Radiol. 2023 Nov;96(1151):20221160. doi: 10.1259/bjr.20221160. Epub 2023 Oct 3.

DOI:10.1259/bjr.20221160
PMID:37660683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10607396/
Abstract

OBJECTIVES

To investigate relationships between histogram-based high-resolution CT (HRCT) indexes and pulmonary function tests (PFTs) in interstitial lung diseases.

METHODS

Forty-nine patients having baseline and 1-year HRCT examinations and PFTs were investigated. Histogram-based HRCT indexes were calculated; strength of associations with PFTs was investigated using Pearson correlation. Patients were divided into progressive and non-progressive groups. HRCT indexes were compared between the two groups using the -test; within each group, baseline and follow-up Wilcoxon analysis was performed. Receiver operating characteristic analysis was used for predicting disease progression.

RESULTS

At baseline, moderate correlations were observed considering kurtosis and diffusion capacity of the lungs for carbon monoxide (DLCO) ( = 0.54) and skewness and DLCO ( = 0.559), whereas weak but significant correlations were observed between forced vital capacity and kurtosis ( = 0.368, = 0.009) and forced vital capacity and skewness ( = 0.391, = 0.005). Negative correlations were reported between HAA% and PFTs (from = -0.418 up to = -0.507). At follow-up correlations between quantitative indexes and PFTs were also moderate, except for high attenuation area (HAA)% -700 and DLCO ( = -0.397). In progressive subgroup, moderate and strong correlations were found between DLCO and HRCT indexes ( = 0.595 kurtosis, = 0.672 skewness, r=-0. 598 HAA% -600 and = -0.626 HAA% -700). At follow-up, we observed significant differences between the two groups for kurtosis ( = 0.029), HAA% -600 ( = 0.04) and HAA% -700 ( = 0.02). To predict progression, ROC analysis reported sensitivity of 90.9% and specificity of 51.9% using a threshold value of δ kurtosis <0.03.

CONCLUSION

At one year, moderate correlations suggest that progression could be assessed through HRCT quantification.

ADVANCES IN KNOWLEDGE

This study promotes histogram-based HRCT indexes in the assessment of progressive pulmonary fibrosis.

摘要

目的

研究基于高分辨率 CT(HRCT)直方图的指标与肺间质疾病的肺功能检查(PFT)之间的关系。

方法

对 49 例基线和 1 年 HRCT 检查及 PFT 患者进行调查。计算基于直方图的 HRCT 指标;采用 Pearson 相关分析探讨与 PFT 的关联强度。将患者分为进展组和非进展组。使用 t 检验比较两组之间的 HRCT 指标;在每组内进行基线和随访 Wilcoxon 分析。采用受试者工作特征分析(ROC)预测疾病进展。

结果

在基线时,峰度和一氧化碳弥散量(DLCO)( = 0.54)以及偏度和 DLCO( = 0.559)之间观察到中度相关,而用力肺活量与峰度( = 0.368, = 0.009)和用力肺活量与偏度( = 0.391, = 0.005)之间存在弱但显著的相关性。HAA%与 PFT 之间存在负相关(从 = -0.418 到 = -0.507)。在随访时,除了高衰减区(HAA)% -700 和 DLCO 外,定量指标与 PFT 之间的相关性也呈中度( = -0.397)。在进展亚组中,DLCO 与 HRCT 指标之间存在中度和高度相关性( = 0.595 峰度, = 0.672 偏度,r=-0.598 HAA% -600, = -0.626 HAA% -700)。在随访时,我们观察到两组之间的峰度( = 0.029)、HAA% -600( = 0.04)和 HAA% -700( = 0.02)有显著差异。为了预测进展,ROC 分析报告使用阈值 δ 峰度 <0.03 时的敏感性为 90.9%,特异性为 51.9%。

结论

在 1 年内,中度相关性表明可以通过 HRCT 定量评估进展。

知识进展

本研究促进了基于直方图的 HRCT 指标在评估进行性肺纤维化中的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/10607396/85d12674812f/bjr.20221160.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/10607396/e7f5b55e58da/bjr.20221160.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/10607396/1fcc1b1aa4b9/bjr.20221160.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/10607396/4ed992cc1b31/bjr.20221160.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/10607396/45645df45bf8/bjr.20221160.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/10607396/30ea4b7844e3/bjr.20221160.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/10607396/efbf0fefcc5c/bjr.20221160.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/10607396/272d0652d30d/bjr.20221160.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/10607396/85d12674812f/bjr.20221160.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/10607396/e7f5b55e58da/bjr.20221160.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/10607396/1fcc1b1aa4b9/bjr.20221160.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/10607396/4ed992cc1b31/bjr.20221160.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/10607396/45645df45bf8/bjr.20221160.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/10607396/30ea4b7844e3/bjr.20221160.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/10607396/efbf0fefcc5c/bjr.20221160.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/10607396/272d0652d30d/bjr.20221160.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48d/10607396/85d12674812f/bjr.20221160.g008.jpg

相似文献

1
Histogram-based analysis in progressive pulmonary fibrosis: relationships between pulmonary functional tests and HRCT indexes.基于直方图分析的进展性肺纤维化:肺功能测试与 HRCT 指标之间的关系。
Br J Radiol. 2023 Nov;96(1151):20221160. doi: 10.1259/bjr.20221160. Epub 2023 Oct 3.
2
Quantitative Evaluation of Fibrosis in IPF Patients: Meaning of Diffuse Pulmonary Ossification.特发性肺纤维化患者纤维化的定量评估:弥漫性肺骨化的意义
Diagnostics (Basel). 2021 Jan 12;11(1):113. doi: 10.3390/diagnostics11010113.
3
Assessment of survival in patients with idiopathic pulmonary fibrosis using quantitative HRCT indexes.使用定量HRCT指标评估特发性肺纤维化患者的生存率
Multidiscip Respir Med. 2018 Dec 1;13:43. doi: 10.1186/s40248-018-0155-2. eCollection 2018.
4
Assessment of Lung Cancer Development in Idiopathic Pulmonary Fibrosis Patients Using Quantitative High-Resolution Computed Tomography: A Retrospective Analysis.采用定量高分辨率计算机断层扫描评估特发性肺纤维化患者的肺癌发展:回顾性分析。
J Thorac Imaging. 2020 Mar;35(2):115-122. doi: 10.1097/RTI.0000000000000468.
5
Quantitative Follow-Up Assessment of Patients with Interstitial Lung Disease by 3D-Curved High-Resolution CT Imaging Parallel to the Chest Wall.采用平行于胸壁的三维曲面高分辨率CT成像对间质性肺疾病患者进行定量随访评估。
Nagoya J Med Sci. 2019 Feb;81(1):41-53. doi: 10.18999/nagjms.81.1.41.
6
Quantitative CT evaluation in patients with combined pulmonary fibrosis and emphysema: correlation with pulmonary function.合并肺纤维化和肺气肿患者的定量CT评估:与肺功能的相关性
Acad Radiol. 2015 May;22(5):626-31. doi: 10.1016/j.acra.2015.01.008. Epub 2015 Feb 27.
7
Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis.系统性硬化症中系列高分辨率 CT 分析和同期肺功能检测的预测价值。
Arthritis Rheumatol. 2015 May;67(8):2205-12. doi: 10.1002/art.39166.
8
Chronic hypersensitivity pneumonitis or idiopathic pulmonary fibrosis? Diagnostic role of high resolution Computed Tomography (HRCT).慢性过敏性肺炎还是特发性肺纤维化?高分辨率计算机断层扫描(HRCT)的诊断作用。
Radiol Med. 2003 Sep;106(3):135-46.
9
Clinical impact of high-attenuation and cystic areas on computed tomography in fibrotic idiopathic interstitial pneumonias.高衰减区和囊性区域在纤维化性特发性间质性肺炎计算机断层扫描中的临床影响
BMC Pulm Med. 2015 Jul 24;15:74. doi: 10.1186/s12890-015-0069-0.
10
Quantitative CT indexes in idiopathic pulmonary fibrosis: relationship with physiologic impairment.特发性肺纤维化的定量CT指标:与生理功能损害的关系
Radiology. 2003 Aug;228(2):407-14. doi: 10.1148/radiol.2282020274. Epub 2003 Jun 11.

引用本文的文献

1
Quantitative Assessment of High-resolution Computer Tomography Imaging in a Super-responder to Nintedanib Therapy in a Patient with Idiopathic Pulmonary Fibrosis.特发性肺纤维化患者中尼达尼布治疗超级反应者的高分辨率计算机断层扫描成像定量评估
Intern Med. 2025;64(10):1552-1562. doi: 10.2169/internalmedicine.4493-24. Epub 2025 May 15.
2
The density histograms-derived computerized integrated index (CII) predicts mortality in idiopathic pulmonary fibrosis.基于密度直方图的计算机化综合指数(CII)可预测特发性肺纤维化患者的死亡率。
Sci Rep. 2024 Dec 28;14(1):30680. doi: 10.1038/s41598-024-77328-3.
3
Artificial intelligence-based quantification of pulmonary HRCT (AIqpHRCT) for the evaluation of interstitial lung disease in patients with inflammatory rheumatic diseases.

本文引用的文献

1
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化(更新版)和成人进展性肺纤维化:美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2022 May 1;205(9):e18-e47. doi: 10.1164/rccm.202202-0399ST.
2
Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.进行性纤维性间质性肺疾病:尼达尼布的新概念和适应证。
Mod Rheumatol. 2021 Jan;31(1):13-19. doi: 10.1080/14397595.2020.1826665.
3
Longitudinal functional changes with clinically significant radiographic progression in idiopathic pulmonary fibrosis: are we following the right parameters?
基于人工智能的肺部高分辨率 CT(AIqpHRCT)定量分析用于评估炎症性风湿病患者的间质性肺疾病。
Rheumatol Int. 2024 Nov;44(11):2483-2496. doi: 10.1007/s00296-024-05715-0. Epub 2024 Sep 9.
特发性肺纤维化有临床意义的放射学进展的纵向功能变化:我们选择的参数是否正确?
Respir Res. 2020 May 19;21(1):119. doi: 10.1186/s12931-020-01371-7.
4
Association of Computed Tomography Densitometry with Disease Severity, Functional Decline, and Survival in Systemic Sclerosis-associated Interstitial Lung Disease.计算机断层扫描密度测定法与系统性硬化症相关间质性肺疾病的疾病严重程度、功能衰退及生存率的关联
Ann Am Thorac Soc. 2020 Jul;17(7):813-820. doi: 10.1513/AnnalsATS.201910-741OC.
5
Automated Computed Tomography analysis in the assessment of Idiopathic Pulmonary Fibrosis severity and progression.自动化计算机断层扫描分析在特发性肺纤维化严重程度和进展评估中的应用。
Eur J Radiol. 2020 Mar;124:108852. doi: 10.1016/j.ejrad.2020.108852. Epub 2020 Jan 28.
6
Treatment of progressive fibrosing interstitial lung diseases: a milestone in the management of interstitial lung diseases.特发性肺纤维化等进行性纤维化性间质性肺疾病的治疗:间质性肺疾病治疗的里程碑。
Eur Respir Rev. 2019 Oct 1;28(153). doi: 10.1183/16000617.0109-2019. Print 2019 Sep 30.
7
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.尼达尼布治疗进行性纤维化间质性肺疾病。
N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29.
8
Fibrosing interstitial lung diseases: knowns and unknowns.纤维性间质性肺疾病:已知与未知。
Eur Respir Rev. 2019 Feb 27;28(151). doi: 10.1183/16000617.0100-2018. Print 2019 Mar 31.
9
Lung CT Densitometry in Idiopathic Pulmonary Fibrosis for the Prediction of Natural Course, Severity, and Mortality.特发性肺纤维化的肺部 CT 密度测定对自然病程、严重程度和死亡率的预测。
Chest. 2019 May;155(5):972-981. doi: 10.1016/j.chest.2019.01.019. Epub 2019 Feb 8.
10
Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases.进行性纤维性间质性肺疾病谱的表现、诊断和临床过程。
Eur Respir Rev. 2018 Dec 21;27(150). doi: 10.1183/16000617.0076-2018. Print 2018 Dec 31.